Celularity Inc. Files 8-K on Financials

Ticker: CELUW · Form: 8-K · Filed: May 9, 2025 · CIK: 1752828

Sentiment: neutral

Topics: financial-reporting, 8-K, company-update

Related Tickers: CELU

TL;DR

CELU filed an 8-K on May 9th detailing financial results and exhibits.

AI Summary

Celularity Inc. filed an 8-K on May 9, 2025, reporting on its results of operations and financial condition, and providing financial statements and exhibits. The company, formerly GX Acquisition Corp., is incorporated in Delaware and headquartered in Florham Park, New Jersey.

Why It Matters

This filing provides investors with crucial updates on Celularity's financial performance and condition, which can influence investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) that does not appear to contain significant new negative information.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K filing?

The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was this 8-K report filed?

The report was filed on May 9, 2025.

What was Celularity Inc.'s former name?

Celularity Inc.'s former name was GX Acquisition Corp.

In which state is Celularity Inc. incorporated?

Celularity Inc. is incorporated in Delaware.

What is the business address of Celularity Inc.?

The business address is 170 Park Ave, Florham Park, New Jersey, 07932.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 9, 2025 regarding Celularity Inc (CELUW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing